Skip to content

Mireille M Doat

6 papers in the library · publishing 2000-2003

Papers

Sort Most recent Most cited

Characterization of the discriminative stimulus properties of centrally administered (-)-DOM and LSD.

Pharmacology, Biochemistry, and Behavior February 2003 Mireille M Doat, Richard A. Rabin, Jerrold C Winter

Despite the plausible assumption that the effects of hallucinogens predominantly arise in the central nervous system, most studies of these drugs in intact subjects have been conducted following systemic administration. The objective of the present investigation was to characterize the stimulus effects of (-)2,5-dimethoxy-4-methylamphetamine ((-)-DOM) following intracerebroventricular...

The effects of acute and subchronic treatment with fluoxetine and citalopram on stimulus control by DOM.

Pharmacology, Biochemistry, and Behavior December 2002 Jerrold C Winter, Justin R Eckler, Mireille M Doat et al.

Previous reports from our laboratory have provided evidence that acute, i.e., concurrent, treatment with selective serotonin reuptake inhibitors (SSRIs) augments the stimulus effects of indoleamine and phenethylamine hallucinogens in the rat. In the present investigation, the acute effects of fluoxetine and citalopram on stimulus control induced by (-)-2,5-dimethoxy-4-methylamphetamine (DOM)...

Potentiation of DOM-induced stimulus control by fluoxetine and citalopram: role of pharmacokinetics.

Life Sciences August 2, 2002 Justin R Eckler, Mireille M Doat, R A Rabin et al.

The present investigation examined the interaction between 2,5-dimethoxy-4-methylamphetamine [DOM] and the selective serotonin reuptake inhibitor [SSRI] citalopram in rats trained with DOM [0.6 mg/kg; 75 min pretreatment time] as a discriminative stimulus. Pretreatment with citalopram at a dose of 1.0 mg/kg shifted the DOM dose response relationship to the left. Unlike previously tested SSRI's,...

The effect of chronic treatment with clozapine and haloperidol on stimulus control by DOM.

The International Journal of Neuropsychopharmacology June 2002 Mireille M Doat, Richard A. Rabin, Jerrold C Winter

The present study investigated the effects of chronic treatment with the atypical antipsychotic, clozapine, or the typical antipsychotic, haloperidol, on the stimulus properties of 2,5-dimethoxy-4-methylamphetamine ([-]-DOM) in rats trained to discriminate [-]-DOM (0.3 mg/kg; 75 min pre-treatment time) from vehicle. As compared with control values, treatment with clozapine (25 mg/kg.d) for 7 d...

5-HT2A receptor-stimulated phosphoinositide hydrolysis in the stimulus effects of hallucinogens.

Pharmacology, Biochemistry, and Behavior May 2002 Richard A. Rabin, Meredith J. Regina, Mireille M Doat et al.

The role of 5-HT2A-mediated stimulation of phosphoinositide hydrolysis in the discriminative effects of hallucinogens was investigated in PC12 cells stably expressing the rat 5-HT2A receptor (PC12-5-HT2A cells). The hallucinogenic compounds, D-lysergic acid diethylamide (LSD), (-)2,5-dimethoxy-4-methylamphetamine (DOM), psilocybin, N,N-dimethyltryptamine (DMT), 5-methoxy-N,N-dimethyltryptamine...

Potentiation of DOM-induced stimulus control by non-competitive NMDA antagonists: a link between the glutamatergic and serotonergic hypotheses of schizophrenia.

Life Sciences December 8, 2000 Jerrold C Winter, Mireille M Doat, R A Rabin

The present investigation examined the interaction between 2,5-dimethoxy-4-methylamphetamine [DOM] and non-competitive NMDA antagonists in rats trained with DOM [0.6 mg/kg; 75 min pretreatment time] as a discriminative stimulus. Pretreatment with phencyclidine [PCP] at a dose of 3 mg/kg shifted the DOM dose-response relationship to the left. When a fixed dose of DOM [0.1 mg/kg] which by itself...